SCHEMBL26700014

SCHEMBL26700014

CCNC(=O)CCNC(=O)CCNC(=O)/C=C\C(C)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.40
ALDH1A1 P00352 3/20 0.36
CNR1 P21554 4/20 0.36
CNR2 P34972 2/20 0.36
CASP2 P42575 1/20 0.35
HDAC3 O15379 2/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
MCL1 Q07820 1/20 0.33
EPHX2 P34913 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
LPAR1 Q92633 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26700010 1.00 FAAH (0.40) FAAHALDH1A1CNR1CNR2CASP2
SCHEMBL2542740 0.80 SLC6A19 (0.40) FAAHALDH1A1CNR1CNR2MCL1
SCHEMBL2542736 0.80 SLC6A19 (0.40) FAAHALDH1A1CNR1CNR2MCL1
SCHEMBL25146405 0.77 ECE1 (0.41) FAAHALDH1A1CNR1CNR2HDAC3
SCHEMBL26700000 0.76 ALDH1A1 (0.39) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL10080737 0.76 ZDHHC20 (0.53) FAAHALDH1A1CASP2MCL1EPHX2
SCHEMBL26700020 0.75 FAAH (0.47) FAAHALDH1A1CASP2MCL1EPHX2
SCHEMBL12424179 0.74 FAAH (0.50) FAAHALDH1A1CASP2MCL1EPHX2
SCHEMBL12673154 0.74 KMT2A (0.58) FAAHALDH1A1CASP2MCL1EPHX2
SCHEMBL16410996 0.73 SLC6A5 (0.44) FAAHCNR1CNR2CASP2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230346951-A1 MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS YALE UNIVERSITY 2023-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230346951-A1 MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS ASGR1, MSR1, LDLR FAAH 2302/4885ALDH1A1 1363/4885CNR1 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.